Saltar al contenido
Merck

Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084.

The Journal of antibiotics (2006-07-13)
Takeshi Isoda, Hideki Ushirogochi, Koichi Satoh, Tsuyoshi Takasaki, Itsuki Yamamura, Chisato Sato, Ado Mihira, Takao Abe, Satoshi Tamai, Shigeki Yamamoto, Toshio Kumagai, Yoshimitsu Nagao
RESUMEN

We discovered an orally active carbapenem, L-084, through pharmacokinetic studies on various prodrug esters of (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-l-methyl-2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-1-carbapen-2-em-3-carboxylic acid (LJC11,036). L-084 showed a strong antimicrobial activity against Gram-positive and Gram-negative bacteria and exhibited the highest intestinal absorption among synthesized prodrugs of LJC11,036.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Tebipenem pivoxil, ≥98% (HPLC)